ISSN 2736-1748
African Journal of AIDS and HIV Research ISSN 2326-2691 Vol. 3 (6), pp. 078-077, June, 2015. © International Scholars Journals
Case Report
Managed virological reaction after treatment with daclatasvir/pegylated interferon and ribavirin as a component of a clinical trial in a cirrhotic human immunodeficiency infection
*William Grant caine, Balogun V. Ayo and Funmilayo Odukoya
Department of Infection and Immunology, Loughborough University, Loughborough, England.
E-mail: [email protected]
Accepted 19 April, 2015
Abstract
This study presents a case of a sustained virological response to 24 weeks early cessation of hepatitis C direct acting antiviral (DAA) treatment with daclatasvir/peginterferon (PEG-IFN)/ribavirin (RBV), mandated by liver decompensation, in a clinical trial subject with advanced liver disease and human immunodeficiency virus (HIV)/hepatitis C virus (HCV) co-infection.
Key words: Human immunodeficiency virus (HIV), hepatitis C, daclatasvir, liver decompensation, sustained virological response, HIV/hepatitis C co-infection.